| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Aptose Biosciences Inc. | Former Officer | Employee Stock Option (Right to Buy) | 11,000 | 05 Feb 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| APTOF | Aptose Biosciences Inc. | 23 Feb 2024 | 0 | $0 | 4 | Former Officer | 10 May 2024, 11:35 |
| APTOF | Aptose Biosciences Inc. | 05 Feb 2024 | 1 | $0 | 4 | Sr VP & Ch Commerical Officer | 07 Feb 2024, 17:26 |
| APTOF | Aptose Biosciences Inc. | 19 Jan 2023 | 2 | $0 | 4 | Chief Commercial Officer | 23 Jan 2023, 18:55 |
| APTOF | Aptose Biosciences Inc. | 13 Apr 2022 | 1 | $0 | 4 | Chief Commercial Officer | 14 Apr 2022, 20:59 |
| APTOF | Aptose Biosciences Inc. | 07 Apr 2022 | 0 | $0 | 3 | Chief Commercial Officer | 14 Apr 2022, 20:58 |